Lecture 15 kidney- pathology

Areej Abu Hanieh
Areej Abu HaniehPharmacist à Birzeit University Student

Lecture 15 kidney- pathology

408 
 
Abnormalities of the kidney and urinary tract
Lecture 15
Functions of the Kidney
 Excretion of metabolic wastes
 Regulation of mineral and water balance
 Release of renin that is important in regulation of blood pressure and blood volume
 Release of erythropoietin in response to hypoxia; erythropoietin stimulates the production
of red blood cells in the bone marrow
 Hydroxylates 25-OH-cholecalciferol (vitamin D metabolite), to promote bone resorption
(the process by which osteoclasts break down bone and release the minerals, resulting in
a transfer of calcium from bone fluid to the blood) and calcium and phosphorus
absorption from the gut
409 
 
Disorders of the kidney
• In order for the kidneys to function normally three things must occur.
 First, there must be adequate blood flow through the glomerular capillaries.
 Second, the glomerular capillaries, which selectively filter blood, must be intact.
Normal glomeruli allow fluids and small solutes to be filtered into the renal tubules
but not proteins or blood cells.
 Third, the tubules of the kidney must be able to reabsorb essential substances
selectively from the filtrate while excreting other substances into the filtrate to be
eliminated in the final urine.
Renin & Erythropoietin
• The juxtaglomerular apparatus consists of three cells:
 The macula densa, a part of the distal convoluted tubule of the same nephron
 Juxtaglomerular cells, which secrete Renin
 Extraglomerular mesangial cells
• Erythropoietin (EPO) is produced by interstitial fibroblasts in the kidney in close
association with peritubular capillary and proximal convoluted tubule.
• It is also produced in perisinusoidal cells in the liver.
• While liver production predominates in the fetal and perinatal period, renal production is
predominant during adulthood
410 
 
RAAS
Nephron Structure 1) Glomerulus
• Basic structural and functional unit of the kidney
• About 1 million nephrons in each kidney
• Consists of glomerulus and renal tubule
411 
 
1) Glomerulus
• Tuft(‫،ﺣﺰﻣﺔ‬ ‫)ﺑﺎﻗﺔ‬of capillaries supplied by an afferent glomerular arteriole that
recombine into an efferent glomerular.
• These capillaries are unusual in having a high blood pressure which is necessary
for maintaining an effective glomerular filtration rate (GFR) to produce the
plasma filtrate from which urine will be made.
• Material is filtered by a 3-layered glomerular filter
• Inner: fenestrated capillary endothelium
• Middle: basement membrane
• Outer: capillary endothelial cells (with foot processes{Podocytes} and
filtration slits)
• Mesangial cells: contractile phagocytic cells that hold the capillary tuft together;
regulate caliber of capillaries affecting filtration rate
Glomerulus Structure
• glomerulus - The network or tuft of fenestrated capillary endothelial cells covered by a
layer of specialized epithelial cells (the visceral layer of the renal corpuscle), the
podocytes, through which water and small dissolved solutes pass to enter the capsular
space of the renal corpuscle of the nephron of the kidney;
412 
 
2) Renal Tubules
• Renal tubule: reabsorbs most of filtrate; secretes unwanted components into tubular
fluid; regulates H2O balance
• Proximal end: Bowman’s capsule
• Distal end: empties into collecting tubules
• Requirements for normal renal function
• Free flow of blood through the glomerular capillaries
• Normally functioning glomerular filter that restricts passage of blood cells and
protein
• Normal outflow of urine
Nephron Structure
413 
 
Nephron Function
Assessment of Kidney Function
 Urinalysis
 Proteinuria - indicates glomerular damage
 Glycosuria - indicates tubular damage
 Urine volume and osmolarity
 pH
 Enzymes - indicates tubular damage
 Microscopic examination - casts, crystals, bacteria, etc.
PH & Specific gravity
• PH: 6.5
• aciduria: acidosis
• alkaluria : alkalosis , renal tubular acidosis
• Specific gravity: 1.015-1.025
• lower SG: chronic renal failure, diabetes insipidus
414 
 
• high SG: acute nephritis, diabetes mellitus, heart failure
 Diabetes Insipidus: occurs when the kidneys cannot concentrate the urine normally, and a
large amount of dilute urine is excreted. It is caused by a failure of the kidneys to respond
to ADH
Microscopic examination of the urine
Assessment of Kidney Function
Blood Chemistries
 Blood urea nitrogen (BUN)
 Creatinine
 Electrolytes - Ca, Mg, K, P
 Glomerular filtration rate - determines the clearance of inulin, creatinine and BUN
 Renal clearance - measures the clearance of p-aminohippuric acid by filtration and
secretion
415 
 
NPN (Non - Protein Nitrogen)
 NPN (Non - Protein Nitrogen) is a “funky” ( ‫ﺗﻘﻠﻴﺪﻱ‬ ‫)ﻏﻴﺮ‬ term that can be used for a bunch
of different substances that have the element nitrogen in them, but are not proteins.
 This is a little unusual, because most of the body’s nitrogen is associated with proteins.
 There are many different unrelated NPNs, but we are only interested in 4 of them:
 Creatinine , Blood Urea Nitrogen ( BUN ) , Uric Acid and Ammonia
 In general, plasma NPNs are increased in renal failure and are commonly ordered as
blood tests to check renal function
BUN (Blood Urea Nitrogen)
 Blood Urea Nitrogen = BUN = Urea
 50% of the NPNs
 Product of protein catabolism which produces ammonia
 Ammonia is very toxic.
 Liver converts ammonia and CO2 to Urea
 Filtered by the glomerulus but also reabsorbed by renal tubules ( 40 % )
o Some is lost through the skin and the GI tract ( < 10 % )
o Plasma BUN is affected by
 Renal function
 Dietary protein
 Protein catabolism
 Reference range:10 – 20 mg / dl
 To convert BUN to Urea : BUN x 2.14 = Urea (mg / dl)
BUN disease correlations
Azotemia = Elevated plasma BUN
 Prerenal  BUN ( Not related to renal function )
o Low Blood Pressure( CHF, Shock, hemorrhage, dehydration)
o Decreased blood flow to kidney = No filtration
o Increased dietary protein or protein catabolism
416 
 
 Prerenal  BUN ( Not related to renal function )
o Decreased dietary protein
o Increased protein synthesis ( Pregnant women , children )
 Renal causes of  BUN
o Renal disease with decreased glomerular filtration
o Glomerular nephritis
o Renal failure form Diabetes Mellitus
 Post renal causes of  BUN ( not related to renal function )
o Obstruction of urine flow
o Kidney stones
o Bladder or prostate tumors
o UTIs
CREATININE
 Creatinine is a by-product of skeletal muscle metabolism and is present in the plasma at
relatively constant levels. The main drawback to the use of “creatinine clearance” to
measure renal function is that any condition that increases skeletal muscle breakdown
(sepsis, muscle injury or muscle disease, for example) will elevate levels of serum
creatinine and invalidate the measure.
 Liver : Amino Acids -----------Creatine
 Muscles : Creatine -----------------Phosphocreatine
 Muscles : Phosphocreatine-------- Creatinine
 Creatinine is formed from creatine and creatine phosphate in muscle
 Creatinine formed at a constant rate by the muscles as a function of muscle mass
 Creatinine is removed from the plasma by glomerular filtration
 Creatinine is not secreted or absorbed by the renal tubules
 Therefore :
o Plasma creatinine is a function of glomerular filtration
o It’s a very good test to evaluate renal function
417 
 
Creatinine disease correlations
 Increased plasma creatinine associated with decreased glomerular filtration ( renal
function )
 Glomerular filtration may be 50 % of normal before plasma creatinine is elevated
 Plasma creatinine is influenced by dietary protein intake to variable degrees; this rise
may be even more exaggerated in patients with renal disease. For this it should be
measured in the fasting state in all patients.
 Plasma creatinine concentrations are very stable from day to day - If there is a delta
check , its very suspicious and must be investigated
 Reference range: 0.5 - 1.2 mg / dl
BUN / Creatinine Ratio
Uric acid
 Breakdown product of purines ( nucleic acid / DNA )
 Purines from cellular breakdown are converted to uric acid by the liver
 Uric acid is filtered by the glomerulus ( but 98 – 100 % reabsorbed )
 Elevated plasma uric acid can promote formation of solid uric acid crystals in
joints and urine
418 
 
Uric acid diseases
o Gout
o Increased plasma uric acid
o Painful uric acid crystals in joints
o Usually in older males ( > 30 years-old )
o Associated with alcohol consumption
o Uric acid may also form kidney stones
o Other causes of increased uric acid
o Leukemias and lymphomas ( DNA catabolism)
o Megaloblastic anemias (  DNA catabolism )
o Renal disease ( but not very specific )
• Reference range: 3.5 - 7.2 mg/dl (males)
2.6 - 6.0 mg/dl (females)
• Let’s remember 3.0 - 7.0 mg/dl
Ammonia
 Produced from the deamaination of amino acids in the muscle and from bacteria
in the GI tract
 Ammonia is very toxic - The liver converts ammonia into urea
 Urea is less toxic and can be removed from the plasma by the kidneys
 In severe hepatic disease, the liver fails to convert ammonia into urea, resulting in
increased plasma ammonia levels
 Increased plasma ammonia concentrations in :
 Liver failure
 Reye’s Syndrome :(Skin rash, vomiting, hypoglycemia and liver damage
associated with aspirin consumption by children with viral illness, it also
occurs in the absence of aspirin use).
 Reference range: 20 – 60 µg / dl
419 
 
Creatinine Clearance
 Calculated measurement of the rate at which creatinine is removed from the plasma by
the kidneys
 Measurement of glomerular filtration (renal function )
 A good test of glomerular filtration because
 Creatinine is an endogenous substance.
 Creatinine is filtered by the glomerulus, but not secreted or re-absorbed by the
renal tubules
 24 Hour Urine collection
 Reference range = 90 - 130 ml / min
NPN TOP 10
1) Increased Creatinine associated with renal failure
2) Increased BUN associated with renal failure and protein catabolism
3) Increased Uric Acid associated with Gout
4) Increased Ammonia is associated with liver disease
5) Creatinine derived from cellular creatine …
6) Delta checks on plasma Creatinine must be investigated!!!
7) BUN ( Urea ) is derived from protein catabolism
8) Protein Ammonia Urea
9) Uric Acid is derived from purine ( a component of DNA ) catabolism
10) Decreased Creatinine Clearance associated with decreased Glomerular Filtration
Delta checks: A comparison of consecutive values for a given test in a patient's laboratory file
used to detect abrupt changes, usually generated as a part of computer-based quality control
programs.
420 
 
Overview of Renal Diseases
Glomerular disease
 Glomerular disease reduces the ability of the kidneys to maintain a balance of certain
substances in bloodstream.
 Normally, the kidneys should filter toxins out of the bloodstream and excrete them in the
urine, but should keep red blood cells and protein in the bloodstream.
 In people with glomerular disease, red blood cells and protein may be excreted into the
urine, while toxins may be retained.
 Glomerular disease can occur by itself (eg, affecting only the kidney), or may be
associated with an underlying medical condition that affects other organ systems, such as
lupus, diabetes, or certain infections.
 Glomerular disease can develop suddenly (acute), or develop slowly over a period of
years (chronic).
 Treatment of glomerular disease depends upon its cause and type.
421 
 
Post-Streptococcal (Acute) glomerulonephritis (PSGN)
 May develop 1 - 2 weeks after an untreated throat infection, or 3 - 4 weeks after a skin
infection (impetigo) infection with group A ((beta-haemolytic) streptococcus. . .
 It may occur in any age (in adults after age 60), but it most often occurs in children ages
5- 12. Trapping of antibody–antigen complexes in glomerular capillaries causes
inflammation of the glomerulus and alters its selective permeability, allowing plasma
proteins and blood cells to enter the kidney filtrate.
 (Proteinuria & Hematuria) , associated with fluid retention, hypertension and edema. This
disorder is uncommon in prosperous countries, common elsewhere.
IgA nephropathy-IgN- (Berger’s disease)
 It is the most common GN in the world with extremely varied presentation usually
including hematuria, mild proteinuria and hypertension.
 Often slowly evolving over decades, may lead to ESRF.
 In young, often acute exacerbations with similarities to post-streptococcal
glomerulonephritis; or occurs with Henoch-Schonlein purpura and vasculitic changes in
glomeruli, skin and bowel (usually self-limiting).
 IgA is deposited in mesangium of glomeruli.
Small vessel vasculitis
 Usually associated with antibodies to neutrophil granule enzymes (ANCA); may cause
aggressive but treatable nephritis, can be associated with severe vasculitis affecting lungs
and other organs.
 Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies.
Glomerulonephritis
 Glomerulonephritis, also known as glomerular nephritis, is a renal disease (usually of
both kidneys) characterized by inflammation of the glomeruli, or capillaries in the
kidneys.
 Majority of the glomerular diseases are caused by antigen-antibody reaction within the
glomeruli.
1) Immune-complex glomerulonephritis
• Usually follows a beta-streptococcal infection
• Circulating antigen and antibody complexes are filtered by glomeruli and incite
inflammation
• Leukocytes release lysosomal enzymes that cause injury to the glomeruli
• Occurs in SLE; immune complexes trapped in glomeruli
• Occurs in IgA nephropathy
422 
 
2) Anti-glomerular basement membrane (anti-GBM) glomerulonephritis:
 autoantibodies attack glomerular basement membrane
 They are categorized into several different pathological patterns, which are broadly
grouped into non-proliferative or proliferative types.
 Diagnosing the pattern of GN is important because the outcome and treatment differs in
different types.
 Primary causes are ones which are intrinsic to the kidney, whilst secondary causes are
associated with certain infections (bacterial, viral or parasitic pathogens), drugs, systemic
disorders (SLE, vasculitis) or diabetes.
Pathogenesis of Acute glomerulonephritis
423 
 
Rapidly progressing glomerulonephritis
 Occurs most commonly in individuals in their 50s and 60s.
 It describes an extreme inflammatory nephritis which causes rapid loss of renal
function over days to weeks.
 Renal biopsy shows crescentic lesions often associated with necrotising lesions within
the glomerulus (focal segmental (necrotising) glomerulonephritis).
 May be idiopathic in origin
 It is typically seen in Goodpasture’s disease, where there are specific anti-GBM
antibodies.
424 
 
Nephrotic Syndrome
 Proteinuria (>3.5g in 24hrs)
o ++++ Protein
o Urine looks frothy
o Tip: Nephrotic & Protein both have an “O” which may help you remember!
 Hypoalbuminemia
o Albumin is lost in the urine
o Due to gaps in Podocytes allowing proteins to escape
 Edema
o Swelling around ankles & eyes
o Due to loss of albumin
o Intravascular oncotic pressure ↓
o Fluid moves out of vessels
 Hyperlipidemia
o Not really understood why this happens
o Just a case of remembering it does!
425 
 
Nephritic Syndrome
 Hematuria
o +++ Blood – May be microscopic or macroscopic haematuria
o Red cell casts – distinguishing feature, form in nephrons & indicate
glomerular damage
o Podocytes develop large pores which allow blood & protein through
 Proteinuria
o ++ Protein (small amount)
 Hypertension
o Usually only mild
 Oliguria (Low urine volume <300ml/day)
o Due to renal function been poor
Nephrotic Syndrome - associated diseases
 Primary causes
o Minimal change Glomerulonephritis
o Focal Segmental Glomerulosclerosis
o Membranous Glomerulonephritis.
 Secondary causes
o SLE
o Hep B & C
o HIV
o Diabetes Mellitus
o Malignancy
o & lots of others
Nephritic Syndrome – associated diseases
 Post streptococcal Glomerulonephritis – appears weeks after URTI
 IgA Nephropathy – appears within a day or two after URTI
 Rapidly progressive Glomerulonephritis (crescentic glomerulonephritis)
426 
 
 Goodpastures - anti GBM antibodies against basal membrane antigens
 Vaculitic disorder – Wegners granulomatosis, Microscopic Polyangitis, Churg
Strauss disease
 Membranoproliferative Glomerulonephritis - primary or secondary to SLE,
Hepatitis B/C etc
 Henoch-Schönlein purpura - systemic vasculitis – deposition of IgA in the skin &
kidneys
427 
 
Chronic glomerulonephritis
 Chronic inflammation of the glomeruli.
 Etiology may be diverse; many patients with chronic glomerulonephritis may have no
history of acute renal disease.
 May be associated with chronic hypertension, diabetes mellitus.
 May remain asymptomatic for a number of years before symptoms of proteinuria,
hematuria occur.
 Progressive loss of renal function occurs over a number of years leading to renal
insufficiency and renal failure.
 Glomerulonephritis Treatment
o Antibiotic therapy if caused by bacterial infection
o Immunosuppressive drugs if autoimmune destruction of glomeruli is occurring
o Management of resulting edema, mineral imbalance and possible hypertension
 Manifestations
o Proteinuria (appearance of protein in the urine, primarily albumin)
o Hematuria (appearance of blood in the urine)
o With chronic forms of glomerulonephritis, decreased urine volume and fluid
retention may occur as renal insufficiency and renal failure develops.
o Hypertension is a possible consequence of reduced renal blood flow and
activation of renin–angiotensin system.
Urinary Tract Infection (UTI)
 Classifications:
1. Upper UTIs are known as Pyelonephritis.
2. Lower UTIs:
a. Ureteritis.
b. Cystitis.
c. Urethritis.
o Women develop UTI more than men because their shorter urethras
428 
 
 Predisposing Factors:
1. Sexual intercourse.
2. Indwelling catheter.
3. Urine stasis.
4. Urinary tract instrumentation.
5. Metabolic disorders
 UTI Clinical Manifestations
1. Upper UTIs:
a. Chills, fever.
b. Malaise.
c. Pain below the ribs.
d. Nausea, Vomiting.
2. Lower UTIs:
a. Back pain .
b. Hematuria.
c. Cloudy urine.
d. Inability to urinate despite the urge.
e. Fever.
f. Frequent need to urinate.
g. General discomfort (malaise).
h. Painful urination (dysuria)
 Diagnostic tests:
1. Urine analysis.
2. Urine culture.
3. WBCs.
 Treatment
o Appropriate antibiotics
o Surgical correction of obstruction or structural abnormality that might be
causing urine retention
o Urinary Tract Infection (cont’d)
429 
 
 Prevention:
1. Avoid products that may irritate the urethra (e.g., bubble bath, scented feminine products).
2. Cleanse the genital area before sexual intercourse.
3. Change soiled diapers in infants and toddlers promptly.
4. Drink plenty of water to remove bacteria from the urinary tract.
5. Do not routinely resist the urge to urinate
6. Take showers instead of baths.
7. Urinate after sexual intercourse.
8. Women and girls should wipe from front to back after voiding to prevent contaminating
the urethra with bacteria from the anal area.
Urolithiasis (Kidney Stones)
 Urolithiasis: The process of forming stones in the kidney, bladder, and/or urethra (urinary
tract).
 Etiology:
1. Immobility.
2. Hypercalcemia.
3. UTIs.
4. Urine stasis.
5. Fractures.
 Clinical Manifestations:
1. Renal colic.
2. Nausea and vomiting accompanying severe pain.
3. Fever and chills.
4. Hematuria.
5. Rarely, oliguria or anuria.
6. Bladder distension (urine retention)
 Diagnostic tests:
1. KUB radiograph reveals visible calculi.
2. IVP (Intravenous Pyelogram) determines size and location of calculi.
3. Renal Ultrasonography reveals obstructive changes.
430 
 
 Treatment
1. Preventative measures include increased fluid intake, acidification of the urine
and reduction of serum uric acid levels.
2. Surgical removal of stones.
3. Lithotripsy— Ultrasonic destruction of stones. Fragmented stones may then pass
naturally with the urine.
Renal tumors
 Tumors of the kidney may be either :
 rare benign Adenomas or, more commonly, malignant renal cell carcinomas
 If benign adenomas arise, they tend to be small and usually not clinically significant.
 The prognosis for renal cell carcinomas depends upon the morphology of the cells
involved and the extent of spread outside the kidney.
 Renal carcinomas may metastasize to the lymphatic system, liver, lungs and bone
marrow.
 Wilm’s tumor (nephroblastoma)
o Rare malignant tumor that arises in infants and children.
o The tumor presents with unique histology that may resemble embryonic kidney.
o Tumor can metastasize rapidly.
 Manifestations
o Hematuria
o Flank pain
o Weight loss
o Many renal tumors asymptomatic until the tumor is of advanced size and begins
to disrupt renal structures
o Metastatic tumors that can occur with advanced disease
 Treatment
o Chemotherapy, radiation therapy
o Surgical removal of tumors
Polycystic kidney disease
 Hereditary disease characterized by cyst formation and massive kidney enlargement.
 It can be Autosomal dominant (adult form) or autosomal recessive (childhood form)
431 
 
 Pathophysiology:
 Renal cysts are fluid-filled sacs affecting nephrons; cysts fill, enlarge, multiply
thus compressing and obstructing kidney tissue; renal parenchyma atrophies,
becomes fibrotic and there is a progressive loss of renal function that may
culminate in renal failure.
 Cysts occur elsewhere in body including liver, spleen
 Cysts develop in both kidneys and gradually increase in size. As normal kidney tissue is
destroyed by the enlarging cysts The recessive form of the disease may cause renal
failure in childhood while the dominant form progresses more slowly and generally does
not lead to renal failure until patients enter their 60s or 70s.
 Adult form accounts for 10% of persons in End Stage Renal Disease (ESRD)
 Manifestations
o Grossly enlarged kidneys
o Hypertension from activation of the renin–angiotensin system
o Renal insufficiency leading to renal failure
o Pain in the flanks
o Frequent infections
 Treatment
o Management of renal insufficiency and renal failure with dialysis
o Management of hypertension; patients may be at particular risk for aneurysms and
cerebral hemorrhage
o Renal transplantation
o Antibiotics for frequent infections
432 
 
Renal failure
 Renal failure refers to a significant loss of renal function in both kidneys to the point
where less than 10 to 20% of normal GFR remains.
 Renal failure may occur as an acute and rapidly progressing process or may present as a
chronic form in which there is a progressive loss of renal function over a number of
years.
Acute renal failure
 Abrupt decrease in renal function.
 Regarding the causes of acute renal failure may be prerenal, intrarenal or
postrenal in nature.
 Acute renal failure is often reversible so long as permanent injury to the kidney
has not occurred.
 Causes of Acute Renal Failure
Prerenal failure
o Caused by impaired or reduced blood flow to the kidney Possible causes: shock,
hypotension, anaphylaxis, sepsis Unless blood flow and oxygen delivery are restored
permanent damage to the kidney will result
Intrarenal failure
o Results from acute damage to renal structures
o Possible causes: acute glomerulonephritis, pyelonephritis, may also result from acute
tubular necrosis (ATN), which is damage of kidney structure from exposure to
toxins, solvents, drugs and heavy metals; ATN is the most common cause of acute
renal failure, it accounts 50% of cases of acute renal failure
o Antibiotics & NSAIDs.
Postrenal failure
o Results from conditions that block urine outflow Possible causes: obstruction of urine
outflow by calculi, tumors, prostatic hypertrophy
 Manifestations
o Oliguria (reduced urine output)
o Possible edema and fluid retention
o Elevated blood urea nitrogen levels (BUN) and serum creatinine
o Alterations in serum electrolytes
433 
 
 Treatment
o Prevention of acute renal failure through support of blood pressure and blood volume
o Correction of fluid and electrolyte imbalances
o Dialysis, which may be employed while the kidneys are in the recovery phase
o Low protein, high carbohydrate diet to minimize the formation of nitrogenous wastes
Chronic renal failure
 Chronic renal failure is the end result of progressive kidney damage and loss of function.
 Some of the possible causes of chronic renal failure:
o Chronic glomerulonephritis
o Chronic infections
o Renal obstruction
o Exposure to toxic chemicals, toxins or drugs (aminoglycoside antibiotics)
o Diabetes
o Hypertension
o Nephrosclerosis (atherosclerosis of the renal artery)
o Aminoglycoside antibiotics and nephrotoxicity
 The aminoglycoside antibiotics are a widely used group of drugs that include
agents such as streptomycin, gentamicin and kanamycin.
 The aminoglycosides can be nephrotoxic under certain conditions.
Aminoglycoside toxicity is most likely to occur in elderly people, those with renal
insufficiency or with chronic use.
 Concurrent use of loop diuretics may also compound the adverse renal effects of
the aminoglycosides.
434 
 
 Chronic renal failure is often classified into four progressive stages based on the loss of
GFR
1) Diminished renal reserve — GFR decreased to 35 to 50% of normal
2) Renal insufficiency — GFR decreased to 20 to 35% of normal
3) Renal failure — GFR reduced to less than 20% of normal
4) End-Stage Renal Disease (ESRD) — GFR is less than 5% of normal
 Because the kidneys play such an essential role in a number of physiologic processes,
renal failure is a multisystem disease.
 The kidneys have a tremendous reserve capacity for function and as a result overt
symptoms generally do occur until renal insufficiency is present.
 Vicious cycle of chronic renal failure
There are several physiologic adaptations that occur in the kidneys in response to chronic
renal failure:
o Increased renal blood flow and GFR in functional nephrons
o Hypertrophy of functional nephrons
o In the short term these adaptations may be beneficial, but in the long term the
increased pressure in the kidneys and increased oxygen demand can further
damage the nephrons and worsen renal failure.
 Clinical Manifestations:
1. Decreased appetite and energy level
2. Increased urinary output and fluid intake
3. Bone or joint pain
4. Delayed or absent sexual maturation
5. Growth retardation
6. Dryness and itching of skin
7. Anemia
8. Markedly elevated BUN and creatinine
 Diagnostic Evaluation:
o Determine extent of disease; monitor progression.
1. Serum studies
a. Decreased hematocrit, hemoglobin, Na+, Ca++; increased K+, phosphorous
b. As renal function declines, BUN, uric acid, and creatinine values continue to climb.
435 
 
2. Urine studies:
a. Specific gravity—increased or decreased
b. 24-hour urine for creatinine clearance is decreased (increased creatinine in urine)
reflecting decreased GFR.
c. Changes in total output
3. Many other tests may be ordered to evaluate other systems and extent of disease (ie, chest x-
ray, electrocardiogram)
 Chronic renal failure Complications
 Chronic Renal Failure Treatment
1. Correction of calcium phosphorous imbalance. Administer activated vitamin D to increase
calcium absorption and calcium phosphate binders with meals to bind phosphate in the
gastrointestinal tract.
2. Correction of acidosis with buffers such as Bicitra
3. Diets should meet caloric needs of the child containing adequate protein for development
(1.0–1.5 g/kg per day).
4. Correction of anemia through the use of erythropoietin (Epogen) administered
subcutaneously at home
5. Growth retardation should be evaluated for possible use of growth hormone.
6. Treatment options for end-stage renal disease (ESRD) are hemodialysis, peritoneal
dialysis, or transplantation.
7. Institute dialysis therapy while transplant work-up is in progress.
436 
 
Chronic Renal Failure Summary
Hemodialysis
 Hemodialysis is a procedure in which an “artificial kidney” machine takes the place of
the patient’s own failing kidneys. Using an indwelling catheter, blood is withdrawn from
the patient and passed through a chamber containing a dialysis membrane and clean
dialysate solution.
 Waste products that are in high concentration in the patient’s blood diffuse across the
dialysate membrane and into the dialysate solution.
 The cleaned blood is then returned to the patient via a second catheter.
 Complications to hemodialysis can include risk of infection, hypotension and electrolyte
imbalance.
 Patients receiving hemodialysis must undergo the procedure several times per week for 3
to 6 hours per treatment.
 Newer high flux dialysate membranes and improved dialysate solutions have reduced the
time of each dialysis session by 1 to 2 hours.
437 
 
Peritoneal dialysis
 An alternative to classic hemodialysis is a technique called peritoneal dialysis. With this
technique a “permanent” catheter is implanted into the peritoneal cavity.
 A clean dialysate solution is introduced through this catheter into the peritoneal cavity
and the patient’s own peritoneum (the membrane lining the abdominal cavity) is used as
the dialyzing membrane.
 After a fixed period of time, usually 8 to 48 hours depending on the system and the
frequency of dialysis, the used fluid is withdrawn.
 Complications of this technique may include infections from the catheter, hypotension,
edema and metabolic abnormalities.
 Peritoneal dialysis does, however, offer the advantage that it may be performed in a
patient’s own home and overnight when the patient sleeps.
438 
 
Kidney Transplantation
 The transplant surgery is performed under general anesthesia.
 The operation usually takes 2-4 hours.
 This type of operation is a heterotopic transplant meaning the kidney is placed in a
different location than the existing kidneys.
 (Liver and heart transplants are orthotopic transplants, in which the diseased organ is
removed and the transplanted organ is placed in the same location.)
 The kidney transplant is placed in the front (anterior) part of the lower abdomen, in the
pelvis.
 The original kidneys are not usually removed unless they are causing severe problems
such as uncontrollable high blood pressure, frequent kidney infections, or are greatly
enlarged.
 The artery that carries blood to the kidney and the vein that carries blood away is
surgically connected to the artery and vein already existing in the pelvis of the recipient.
The ureter is connected to the bladder.
 Recovery in the hospital is usually 3-7 days.
 Complications can occur with any surgery.
 The following complications do not occur often but can include:
o Bleeding, infection, or wound healing problems.
o Difficulty with blood circulation to the kidney or problem with flow of urine from
the kidney.
 These complications may require another operation to correct them.
 Rejection is an expected side effect of transplantation and up to 30% of people who
receive a kidney transplant will experience some degree of rejection.
 Most rejections occur within six months after transplantation, but can occur at any time,
even years later. Prompt treatment can reverse the rejection in most cases.
 Anti-Rejection Medications:
o Anti-rejection medications, also known as immunosuppressive agents, help to
prevent and treat rejection.
o They are necessary for the "lifetime" of the transplant. If these medications are
stopped, rejection may occur and the kidney transplant will fail.
439 
 
440 
 
Disorders of the bladder and urethra
Urine reflux
 Urine reflux is the backward flow of urine from the bladder into the ureters and kidneys
(vesicoureteral reflux) or from the urethra into the bladder (urethrovesical reflux)
 Generally results from congenital abnormalities in the structure or location of the ureters
or urethra.
 Patients often present with urine retention and recurrent urinary tract infections.
 Treatment may include antibiotic therapy and possible surgical correction of the
structural abnormality.
Neurogenic bladder
 Bladder paralysis that occurs from interruption of nervous input to the muscles of the
bladder wall.
 Patients are unable to voluntarily or involuntarily empty their bladder.
 Causes may include spinal cord trauma, polio, multiple sclerosis and tumors affecting
spinal nerves.
 Manifestations include marked urine retention, frequent urinary tract infections and
possible deterioration of renal function (postrenal failure).
_____________________

Recommandé

Renal pathology par
Renal pathologyRenal pathology
Renal pathologyraj kumar
44.4K vues294 diapositives
glomerular disease par
glomerular diseaseglomerular disease
glomerular diseaseShruthi Mahesh
10.6K vues65 diapositives
Physiology of kidney par
Physiology of kidneyPhysiology of kidney
Physiology of kidneyZulaikha Jusoh
3.1K vues24 diapositives
Renal anatomy par
Renal anatomyRenal anatomy
Renal anatomyAbino David
37.7K vues29 diapositives
Propulsion and mixing par
Propulsion and mixingPropulsion and mixing
Propulsion and mixingDrChintansinh Parmar
10.9K vues45 diapositives
Gfr par
GfrGfr
GfrDrChintansinh Parmar
22.9K vues47 diapositives

Contenu connexe

Tendances

Renal function test par
Renal function testRenal function test
Renal function testRUPALIMUNDE
1.2K vues32 diapositives
Autoregulation of glomerular filtration rate and renal blood par
Autoregulation of glomerular filtration rate and renal bloodAutoregulation of glomerular filtration rate and renal blood
Autoregulation of glomerular filtration rate and renal bloodDeepa Devkota
9.9K vues18 diapositives
creatinine clearance test par
creatinine clearance testcreatinine clearance test
creatinine clearance testDr.M.Prasad Naidu
47.2K vues41 diapositives
Development of urinary system par
Development of urinary systemDevelopment of urinary system
Development of urinary systemMohamed El Fiky
8.9K vues24 diapositives
Renal physiology 2 par
Renal physiology 2Renal physiology 2
Renal physiology 2manoj000049
3.9K vues39 diapositives
Renal function tests par
Renal function testsRenal function tests
Renal function testsMalini Garg
7.2K vues90 diapositives

Tendances(20)

Renal function test par RUPALIMUNDE
Renal function testRenal function test
Renal function test
RUPALIMUNDE1.2K vues
Autoregulation of glomerular filtration rate and renal blood par Deepa Devkota
Autoregulation of glomerular filtration rate and renal bloodAutoregulation of glomerular filtration rate and renal blood
Autoregulation of glomerular filtration rate and renal blood
Deepa Devkota9.9K vues
Renal physiology 2 par manoj000049
Renal physiology 2Renal physiology 2
Renal physiology 2
manoj0000493.9K vues
Renal function tests par Malini Garg
Renal function testsRenal function tests
Renal function tests
Malini Garg7.2K vues
MECHANISM OF CONCENTRATION OF URINE par Dr Nilesh Kate
MECHANISM OF CONCENTRATION OF URINEMECHANISM OF CONCENTRATION OF URINE
MECHANISM OF CONCENTRATION OF URINE
Dr Nilesh Kate61.6K vues
Urophysiology 5 par Ayub Abdi
Urophysiology 5Urophysiology 5
Urophysiology 5
Ayub Abdi669 vues
Renal physiology introduction. par Shaikhani.
Renal physiology introduction.Renal physiology introduction.
Renal physiology introduction.
Shaikhani.19.2K vues
Renal function tests par velspharmd
Renal function testsRenal function tests
Renal function tests
velspharmd17.5K vues
LIVER PATHOLOGY par Suraj Dhara
LIVER PATHOLOGYLIVER PATHOLOGY
LIVER PATHOLOGY
Suraj Dhara17.2K vues
Autoregulation of Glomerular Filtration Rate par Garima Aggarwal
Autoregulation of Glomerular Filtration RateAutoregulation of Glomerular Filtration Rate
Autoregulation of Glomerular Filtration Rate
Garima Aggarwal57.9K vues
EVENTS OF URINE FORMATION (The Guyton and Hall physiology) par Maryam Fida
EVENTS OF URINE FORMATION (The Guyton and Hall physiology)EVENTS OF URINE FORMATION (The Guyton and Hall physiology)
EVENTS OF URINE FORMATION (The Guyton and Hall physiology)
Maryam Fida796 vues
Blood supply and venous drainage of the gastro-intestinal tract and liver par meducationdotnet
Blood supply and venous drainage of the gastro-intestinal tract and liverBlood supply and venous drainage of the gastro-intestinal tract and liver
Blood supply and venous drainage of the gastro-intestinal tract and liver
meducationdotnet10.5K vues

En vedette

Lecture 18 Hepatitis and liver disorders par
Lecture 18 Hepatitis and liver disordersLecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disordersAreej Abu Hanieh
1.1K vues28 diapositives
Lecture 7 diseases of the vascular system - Pathology par
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Areej Abu Hanieh
1.6K vues27 diapositives
Lecture 19 pancreatitis - Pathology par
Lecture 19 pancreatitis - PathologyLecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyAreej Abu Hanieh
2.6K vues19 diapositives
Renal Pathology Tutorial par
Renal Pathology TutorialRenal Pathology Tutorial
Renal Pathology TutorialChristiane Riedinger
12.1K vues46 diapositives
Pathology - Cancer par
Pathology - CancerPathology - Cancer
Pathology - CancerAreej Abu Hanieh
9.1K vues24 diapositives
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology par
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - PathologyLecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - PathologyAreej Abu Hanieh
2.6K vues28 diapositives

En vedette(20)

Lecture 18 Hepatitis and liver disorders par Areej Abu Hanieh
Lecture 18 Hepatitis and liver disordersLecture 18 Hepatitis and liver disorders
Lecture 18 Hepatitis and liver disorders
Areej Abu Hanieh1.1K vues
Lecture 7 diseases of the vascular system - Pathology par Areej Abu Hanieh
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
Areej Abu Hanieh1.6K vues
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology par Areej Abu Hanieh
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - PathologyLecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Lecture 20 disorders of hypothalamus, pituitary and thyroid glands - Pathology
Areej Abu Hanieh2.6K vues
Lecture 22 diabetes mellitus - pathology par Areej Abu Hanieh
Lecture 22 diabetes mellitus - pathologyLecture 22 diabetes mellitus - pathology
Lecture 22 diabetes mellitus - pathology
Areej Abu Hanieh3.2K vues
Lecture 10 valvular heart disease - Pathology par Areej Abu Hanieh
Lecture 10 valvular heart disease - Pathology Lecture 10 valvular heart disease - Pathology
Lecture 10 valvular heart disease - Pathology
Lecture 17 Colon Disorders - Pathology par Areej Abu Hanieh
Lecture 17 Colon Disorders - PathologyLecture 17 Colon Disorders - Pathology
Lecture 17 Colon Disorders - Pathology
Areej Abu Hanieh1.6K vues
Lecture 16 esophagus and stomach disorders - Pathology par Areej Abu Hanieh
Lecture 16 esophagus and stomach disorders - PathologyLecture 16 esophagus and stomach disorders - Pathology
Lecture 16 esophagus and stomach disorders - Pathology
Areej Abu Hanieh2.1K vues
Lecture 21 adrenal glands diseases - pathology par Areej Abu Hanieh
Lecture 21 adrenal glands diseases - pathologyLecture 21 adrenal glands diseases - pathology
Lecture 21 adrenal glands diseases - pathology
Areej Abu Hanieh2.9K vues

Similaire à Lecture 15 kidney- pathology

Renal function par
Renal functionRenal function
Renal functionAFiFi Faridz
731 vues5 diapositives
Non protein nitrogen par
Non protein nitrogenNon protein nitrogen
Non protein nitrogenShahid Nawaz
38.5K vues26 diapositives
Renal function test par
Renal function testRenal function test
Renal function testKhadga Raj
1.8K vues26 diapositives
RENAL FUNCTION TESTS par
RENAL FUNCTION TESTSRENAL FUNCTION TESTS
RENAL FUNCTION TESTSରବି ହୋତା
740 vues58 diapositives
THE ROLE OF CHEMICAL PATHOLOGY.pptx par
THE ROLE OF CHEMICAL PATHOLOGY.pptxTHE ROLE OF CHEMICAL PATHOLOGY.pptx
THE ROLE OF CHEMICAL PATHOLOGY.pptxNnabuifeLoveday
35 vues32 diapositives
Acute Kidney Injury.pptx par
Acute Kidney Injury.pptxAcute Kidney Injury.pptx
Acute Kidney Injury.pptxMahima Panhalkar
34 vues31 diapositives

Similaire à Lecture 15 kidney- pathology (20)

Non protein nitrogen par Shahid Nawaz
Non protein nitrogenNon protein nitrogen
Non protein nitrogen
Shahid Nawaz38.5K vues
Renal function test par Khadga Raj
Renal function testRenal function test
Renal function test
Khadga Raj1.8K vues
Kidney-Function-Tests par Raghu Veer
 Kidney-Function-Tests Kidney-Function-Tests
Kidney-Function-Tests
Raghu Veer204 vues
Organ function tests par jagan vana
Organ function testsOrgan function tests
Organ function tests
jagan vana2.1K vues
Acute renal failure par cathykwy
Acute renal failureAcute renal failure
Acute renal failure
cathykwy615 vues
renal function.pptx par NabdNabd
renal function.pptxrenal function.pptx
renal function.pptx
NabdNabd3 vues
Renal disease wps office par home
Renal disease wps officeRenal disease wps office
Renal disease wps office
home61 vues

Plus de Areej Abu Hanieh

Announcement about my previous presentations - Thank you par
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAreej Abu Hanieh
9K vues1 diapositive
Infection - penicillins par
Infection - penicillinsInfection - penicillins
Infection - penicillinsAreej Abu Hanieh
2.8K vues31 diapositives
Hospital acquired pneumonia par
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumoniaAreej Abu Hanieh
3.4K vues11 diapositives
catheter related blood stream infection par
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection Areej Abu Hanieh
3.5K vues24 diapositives
Community acquired pneumonia - Pharmacotherapy par
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy Areej Abu Hanieh
1.2K vues18 diapositives
Cellulitis - Treatment par
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - TreatmentAreej Abu Hanieh
14.7K vues23 diapositives

Plus de Areej Abu Hanieh(20)

Announcement about my previous presentations - Thank you par Areej Abu Hanieh
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
catheter related blood stream infection par Areej Abu Hanieh
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
Areej Abu Hanieh3.5K vues
Community acquired pneumonia - Pharmacotherapy par Areej Abu Hanieh
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy
Areej Abu Hanieh1.2K vues
Asthma and COPD exacerbation - Emergency par Areej Abu Hanieh
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
Areej Abu Hanieh1.8K vues
Glycemic Control - Diabetes Mellitus par Areej Abu Hanieh
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
Areej Abu Hanieh1.3K vues

Dernier

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends par
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trendsmuskansbl01
59 vues15 diapositives
vitamin E.pptx par
vitamin E.pptxvitamin E.pptx
vitamin E.pptxajithkilpart
15 vues14 diapositives
Testicular tumors.pptx par
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptxUtkarsh Singhal
32 vues64 diapositives
Explore new Frontiers in Medicine with AI.pdf par
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdfAnne Marie
18 vues31 diapositives
PATIENTCOUNSELLING in.pptx par
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptxskShashi1
45 vues16 diapositives
Complications & Solutions in Laparoscopic Hernia Surgery.pptx par
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptxVarunraju9
135 vues21 diapositives

Dernier(20)

Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends par muskansbl01
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
muskansbl0159 vues
Explore new Frontiers in Medicine with AI.pdf par Anne Marie
Explore new Frontiers in Medicine with AI.pdfExplore new Frontiers in Medicine with AI.pdf
Explore new Frontiers in Medicine with AI.pdf
Anne Marie18 vues
PATIENTCOUNSELLING in.pptx par skShashi1
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi145 vues
Complications & Solutions in Laparoscopic Hernia Surgery.pptx par Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9135 vues
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) par The Swiss Pharmacy
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler) Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
Asthalin Inhaler (Generic Albuterol Sulfate Inhaler)
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl... par DipeshGamare
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
GAS CHROMATOGRAPHY-Principle, Instrumentation Advantage and disadvantage appl...
DipeshGamare18 vues
Buccoadhesive drug delivery System.pptx par ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG167 vues
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective par Golden Helix
VarSeq 2.5.0: VSClinical AMP Workflow from the User PerspectiveVarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
VarSeq 2.5.0: VSClinical AMP Workflow from the User Perspective
Golden Helix108 vues
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad par Swetha rani Savala
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Pulmonary Embolism for Nurses.pptx par Asraf Hussain
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptx
Asraf Hussain36 vues
eTEP -RS Dr.TVR.pptx par Varunraju9
eTEP -RS Dr.TVR.pptxeTEP -RS Dr.TVR.pptx
eTEP -RS Dr.TVR.pptx
Varunraju9148 vues

Lecture 15 kidney- pathology

  • 1. 408    Abnormalities of the kidney and urinary tract Lecture 15 Functions of the Kidney  Excretion of metabolic wastes  Regulation of mineral and water balance  Release of renin that is important in regulation of blood pressure and blood volume  Release of erythropoietin in response to hypoxia; erythropoietin stimulates the production of red blood cells in the bone marrow  Hydroxylates 25-OH-cholecalciferol (vitamin D metabolite), to promote bone resorption (the process by which osteoclasts break down bone and release the minerals, resulting in a transfer of calcium from bone fluid to the blood) and calcium and phosphorus absorption from the gut
  • 2. 409    Disorders of the kidney • In order for the kidneys to function normally three things must occur.  First, there must be adequate blood flow through the glomerular capillaries.  Second, the glomerular capillaries, which selectively filter blood, must be intact. Normal glomeruli allow fluids and small solutes to be filtered into the renal tubules but not proteins or blood cells.  Third, the tubules of the kidney must be able to reabsorb essential substances selectively from the filtrate while excreting other substances into the filtrate to be eliminated in the final urine. Renin & Erythropoietin • The juxtaglomerular apparatus consists of three cells:  The macula densa, a part of the distal convoluted tubule of the same nephron  Juxtaglomerular cells, which secrete Renin  Extraglomerular mesangial cells • Erythropoietin (EPO) is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. • It is also produced in perisinusoidal cells in the liver. • While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood
  • 3. 410    RAAS Nephron Structure 1) Glomerulus • Basic structural and functional unit of the kidney • About 1 million nephrons in each kidney • Consists of glomerulus and renal tubule
  • 4. 411    1) Glomerulus • Tuft(‫،ﺣﺰﻣﺔ‬ ‫)ﺑﺎﻗﺔ‬of capillaries supplied by an afferent glomerular arteriole that recombine into an efferent glomerular. • These capillaries are unusual in having a high blood pressure which is necessary for maintaining an effective glomerular filtration rate (GFR) to produce the plasma filtrate from which urine will be made. • Material is filtered by a 3-layered glomerular filter • Inner: fenestrated capillary endothelium • Middle: basement membrane • Outer: capillary endothelial cells (with foot processes{Podocytes} and filtration slits) • Mesangial cells: contractile phagocytic cells that hold the capillary tuft together; regulate caliber of capillaries affecting filtration rate Glomerulus Structure • glomerulus - The network or tuft of fenestrated capillary endothelial cells covered by a layer of specialized epithelial cells (the visceral layer of the renal corpuscle), the podocytes, through which water and small dissolved solutes pass to enter the capsular space of the renal corpuscle of the nephron of the kidney;
  • 5. 412    2) Renal Tubules • Renal tubule: reabsorbs most of filtrate; secretes unwanted components into tubular fluid; regulates H2O balance • Proximal end: Bowman’s capsule • Distal end: empties into collecting tubules • Requirements for normal renal function • Free flow of blood through the glomerular capillaries • Normally functioning glomerular filter that restricts passage of blood cells and protein • Normal outflow of urine Nephron Structure
  • 6. 413    Nephron Function Assessment of Kidney Function  Urinalysis  Proteinuria - indicates glomerular damage  Glycosuria - indicates tubular damage  Urine volume and osmolarity  pH  Enzymes - indicates tubular damage  Microscopic examination - casts, crystals, bacteria, etc. PH & Specific gravity • PH: 6.5 • aciduria: acidosis • alkaluria : alkalosis , renal tubular acidosis • Specific gravity: 1.015-1.025 • lower SG: chronic renal failure, diabetes insipidus
  • 7. 414    • high SG: acute nephritis, diabetes mellitus, heart failure  Diabetes Insipidus: occurs when the kidneys cannot concentrate the urine normally, and a large amount of dilute urine is excreted. It is caused by a failure of the kidneys to respond to ADH Microscopic examination of the urine Assessment of Kidney Function Blood Chemistries  Blood urea nitrogen (BUN)  Creatinine  Electrolytes - Ca, Mg, K, P  Glomerular filtration rate - determines the clearance of inulin, creatinine and BUN  Renal clearance - measures the clearance of p-aminohippuric acid by filtration and secretion
  • 8. 415    NPN (Non - Protein Nitrogen)  NPN (Non - Protein Nitrogen) is a “funky” ( ‫ﺗﻘﻠﻴﺪﻱ‬ ‫)ﻏﻴﺮ‬ term that can be used for a bunch of different substances that have the element nitrogen in them, but are not proteins.  This is a little unusual, because most of the body’s nitrogen is associated with proteins.  There are many different unrelated NPNs, but we are only interested in 4 of them:  Creatinine , Blood Urea Nitrogen ( BUN ) , Uric Acid and Ammonia  In general, plasma NPNs are increased in renal failure and are commonly ordered as blood tests to check renal function BUN (Blood Urea Nitrogen)  Blood Urea Nitrogen = BUN = Urea  50% of the NPNs  Product of protein catabolism which produces ammonia  Ammonia is very toxic.  Liver converts ammonia and CO2 to Urea  Filtered by the glomerulus but also reabsorbed by renal tubules ( 40 % ) o Some is lost through the skin and the GI tract ( < 10 % ) o Plasma BUN is affected by  Renal function  Dietary protein  Protein catabolism  Reference range:10 – 20 mg / dl  To convert BUN to Urea : BUN x 2.14 = Urea (mg / dl) BUN disease correlations Azotemia = Elevated plasma BUN  Prerenal  BUN ( Not related to renal function ) o Low Blood Pressure( CHF, Shock, hemorrhage, dehydration) o Decreased blood flow to kidney = No filtration o Increased dietary protein or protein catabolism
  • 9. 416     Prerenal  BUN ( Not related to renal function ) o Decreased dietary protein o Increased protein synthesis ( Pregnant women , children )  Renal causes of  BUN o Renal disease with decreased glomerular filtration o Glomerular nephritis o Renal failure form Diabetes Mellitus  Post renal causes of  BUN ( not related to renal function ) o Obstruction of urine flow o Kidney stones o Bladder or prostate tumors o UTIs CREATININE  Creatinine is a by-product of skeletal muscle metabolism and is present in the plasma at relatively constant levels. The main drawback to the use of “creatinine clearance” to measure renal function is that any condition that increases skeletal muscle breakdown (sepsis, muscle injury or muscle disease, for example) will elevate levels of serum creatinine and invalidate the measure.  Liver : Amino Acids -----------Creatine  Muscles : Creatine -----------------Phosphocreatine  Muscles : Phosphocreatine-------- Creatinine  Creatinine is formed from creatine and creatine phosphate in muscle  Creatinine formed at a constant rate by the muscles as a function of muscle mass  Creatinine is removed from the plasma by glomerular filtration  Creatinine is not secreted or absorbed by the renal tubules  Therefore : o Plasma creatinine is a function of glomerular filtration o It’s a very good test to evaluate renal function
  • 10. 417    Creatinine disease correlations  Increased plasma creatinine associated with decreased glomerular filtration ( renal function )  Glomerular filtration may be 50 % of normal before plasma creatinine is elevated  Plasma creatinine is influenced by dietary protein intake to variable degrees; this rise may be even more exaggerated in patients with renal disease. For this it should be measured in the fasting state in all patients.  Plasma creatinine concentrations are very stable from day to day - If there is a delta check , its very suspicious and must be investigated  Reference range: 0.5 - 1.2 mg / dl BUN / Creatinine Ratio Uric acid  Breakdown product of purines ( nucleic acid / DNA )  Purines from cellular breakdown are converted to uric acid by the liver  Uric acid is filtered by the glomerulus ( but 98 – 100 % reabsorbed )  Elevated plasma uric acid can promote formation of solid uric acid crystals in joints and urine
  • 11. 418    Uric acid diseases o Gout o Increased plasma uric acid o Painful uric acid crystals in joints o Usually in older males ( > 30 years-old ) o Associated with alcohol consumption o Uric acid may also form kidney stones o Other causes of increased uric acid o Leukemias and lymphomas ( DNA catabolism) o Megaloblastic anemias (  DNA catabolism ) o Renal disease ( but not very specific ) • Reference range: 3.5 - 7.2 mg/dl (males) 2.6 - 6.0 mg/dl (females) • Let’s remember 3.0 - 7.0 mg/dl Ammonia  Produced from the deamaination of amino acids in the muscle and from bacteria in the GI tract  Ammonia is very toxic - The liver converts ammonia into urea  Urea is less toxic and can be removed from the plasma by the kidneys  In severe hepatic disease, the liver fails to convert ammonia into urea, resulting in increased plasma ammonia levels  Increased plasma ammonia concentrations in :  Liver failure  Reye’s Syndrome :(Skin rash, vomiting, hypoglycemia and liver damage associated with aspirin consumption by children with viral illness, it also occurs in the absence of aspirin use).  Reference range: 20 – 60 µg / dl
  • 12. 419    Creatinine Clearance  Calculated measurement of the rate at which creatinine is removed from the plasma by the kidneys  Measurement of glomerular filtration (renal function )  A good test of glomerular filtration because  Creatinine is an endogenous substance.  Creatinine is filtered by the glomerulus, but not secreted or re-absorbed by the renal tubules  24 Hour Urine collection  Reference range = 90 - 130 ml / min NPN TOP 10 1) Increased Creatinine associated with renal failure 2) Increased BUN associated with renal failure and protein catabolism 3) Increased Uric Acid associated with Gout 4) Increased Ammonia is associated with liver disease 5) Creatinine derived from cellular creatine … 6) Delta checks on plasma Creatinine must be investigated!!! 7) BUN ( Urea ) is derived from protein catabolism 8) Protein Ammonia Urea 9) Uric Acid is derived from purine ( a component of DNA ) catabolism 10) Decreased Creatinine Clearance associated with decreased Glomerular Filtration Delta checks: A comparison of consecutive values for a given test in a patient's laboratory file used to detect abrupt changes, usually generated as a part of computer-based quality control programs.
  • 13. 420    Overview of Renal Diseases Glomerular disease  Glomerular disease reduces the ability of the kidneys to maintain a balance of certain substances in bloodstream.  Normally, the kidneys should filter toxins out of the bloodstream and excrete them in the urine, but should keep red blood cells and protein in the bloodstream.  In people with glomerular disease, red blood cells and protein may be excreted into the urine, while toxins may be retained.  Glomerular disease can occur by itself (eg, affecting only the kidney), or may be associated with an underlying medical condition that affects other organ systems, such as lupus, diabetes, or certain infections.  Glomerular disease can develop suddenly (acute), or develop slowly over a period of years (chronic).  Treatment of glomerular disease depends upon its cause and type.
  • 14. 421    Post-Streptococcal (Acute) glomerulonephritis (PSGN)  May develop 1 - 2 weeks after an untreated throat infection, or 3 - 4 weeks after a skin infection (impetigo) infection with group A ((beta-haemolytic) streptococcus. . .  It may occur in any age (in adults after age 60), but it most often occurs in children ages 5- 12. Trapping of antibody–antigen complexes in glomerular capillaries causes inflammation of the glomerulus and alters its selective permeability, allowing plasma proteins and blood cells to enter the kidney filtrate.  (Proteinuria & Hematuria) , associated with fluid retention, hypertension and edema. This disorder is uncommon in prosperous countries, common elsewhere. IgA nephropathy-IgN- (Berger’s disease)  It is the most common GN in the world with extremely varied presentation usually including hematuria, mild proteinuria and hypertension.  Often slowly evolving over decades, may lead to ESRF.  In young, often acute exacerbations with similarities to post-streptococcal glomerulonephritis; or occurs with Henoch-Schonlein purpura and vasculitic changes in glomeruli, skin and bowel (usually self-limiting).  IgA is deposited in mesangium of glomeruli. Small vessel vasculitis  Usually associated with antibodies to neutrophil granule enzymes (ANCA); may cause aggressive but treatable nephritis, can be associated with severe vasculitis affecting lungs and other organs.  Anti-neutrophil cytoplasmic antibodies (ANCAs) are a group of autoantibodies. Glomerulonephritis  Glomerulonephritis, also known as glomerular nephritis, is a renal disease (usually of both kidneys) characterized by inflammation of the glomeruli, or capillaries in the kidneys.  Majority of the glomerular diseases are caused by antigen-antibody reaction within the glomeruli. 1) Immune-complex glomerulonephritis • Usually follows a beta-streptococcal infection • Circulating antigen and antibody complexes are filtered by glomeruli and incite inflammation • Leukocytes release lysosomal enzymes that cause injury to the glomeruli • Occurs in SLE; immune complexes trapped in glomeruli • Occurs in IgA nephropathy
  • 15. 422    2) Anti-glomerular basement membrane (anti-GBM) glomerulonephritis:  autoantibodies attack glomerular basement membrane  They are categorized into several different pathological patterns, which are broadly grouped into non-proliferative or proliferative types.  Diagnosing the pattern of GN is important because the outcome and treatment differs in different types.  Primary causes are ones which are intrinsic to the kidney, whilst secondary causes are associated with certain infections (bacterial, viral or parasitic pathogens), drugs, systemic disorders (SLE, vasculitis) or diabetes. Pathogenesis of Acute glomerulonephritis
  • 16. 423    Rapidly progressing glomerulonephritis  Occurs most commonly in individuals in their 50s and 60s.  It describes an extreme inflammatory nephritis which causes rapid loss of renal function over days to weeks.  Renal biopsy shows crescentic lesions often associated with necrotising lesions within the glomerulus (focal segmental (necrotising) glomerulonephritis).  May be idiopathic in origin  It is typically seen in Goodpasture’s disease, where there are specific anti-GBM antibodies.
  • 17. 424    Nephrotic Syndrome  Proteinuria (>3.5g in 24hrs) o ++++ Protein o Urine looks frothy o Tip: Nephrotic & Protein both have an “O” which may help you remember!  Hypoalbuminemia o Albumin is lost in the urine o Due to gaps in Podocytes allowing proteins to escape  Edema o Swelling around ankles & eyes o Due to loss of albumin o Intravascular oncotic pressure ↓ o Fluid moves out of vessels  Hyperlipidemia o Not really understood why this happens o Just a case of remembering it does!
  • 18. 425    Nephritic Syndrome  Hematuria o +++ Blood – May be microscopic or macroscopic haematuria o Red cell casts – distinguishing feature, form in nephrons & indicate glomerular damage o Podocytes develop large pores which allow blood & protein through  Proteinuria o ++ Protein (small amount)  Hypertension o Usually only mild  Oliguria (Low urine volume <300ml/day) o Due to renal function been poor Nephrotic Syndrome - associated diseases  Primary causes o Minimal change Glomerulonephritis o Focal Segmental Glomerulosclerosis o Membranous Glomerulonephritis.  Secondary causes o SLE o Hep B & C o HIV o Diabetes Mellitus o Malignancy o & lots of others Nephritic Syndrome – associated diseases  Post streptococcal Glomerulonephritis – appears weeks after URTI  IgA Nephropathy – appears within a day or two after URTI  Rapidly progressive Glomerulonephritis (crescentic glomerulonephritis)
  • 19. 426     Goodpastures - anti GBM antibodies against basal membrane antigens  Vaculitic disorder – Wegners granulomatosis, Microscopic Polyangitis, Churg Strauss disease  Membranoproliferative Glomerulonephritis - primary or secondary to SLE, Hepatitis B/C etc  Henoch-Schönlein purpura - systemic vasculitis – deposition of IgA in the skin & kidneys
  • 20. 427    Chronic glomerulonephritis  Chronic inflammation of the glomeruli.  Etiology may be diverse; many patients with chronic glomerulonephritis may have no history of acute renal disease.  May be associated with chronic hypertension, diabetes mellitus.  May remain asymptomatic for a number of years before symptoms of proteinuria, hematuria occur.  Progressive loss of renal function occurs over a number of years leading to renal insufficiency and renal failure.  Glomerulonephritis Treatment o Antibiotic therapy if caused by bacterial infection o Immunosuppressive drugs if autoimmune destruction of glomeruli is occurring o Management of resulting edema, mineral imbalance and possible hypertension  Manifestations o Proteinuria (appearance of protein in the urine, primarily albumin) o Hematuria (appearance of blood in the urine) o With chronic forms of glomerulonephritis, decreased urine volume and fluid retention may occur as renal insufficiency and renal failure develops. o Hypertension is a possible consequence of reduced renal blood flow and activation of renin–angiotensin system. Urinary Tract Infection (UTI)  Classifications: 1. Upper UTIs are known as Pyelonephritis. 2. Lower UTIs: a. Ureteritis. b. Cystitis. c. Urethritis. o Women develop UTI more than men because their shorter urethras
  • 21. 428     Predisposing Factors: 1. Sexual intercourse. 2. Indwelling catheter. 3. Urine stasis. 4. Urinary tract instrumentation. 5. Metabolic disorders  UTI Clinical Manifestations 1. Upper UTIs: a. Chills, fever. b. Malaise. c. Pain below the ribs. d. Nausea, Vomiting. 2. Lower UTIs: a. Back pain . b. Hematuria. c. Cloudy urine. d. Inability to urinate despite the urge. e. Fever. f. Frequent need to urinate. g. General discomfort (malaise). h. Painful urination (dysuria)  Diagnostic tests: 1. Urine analysis. 2. Urine culture. 3. WBCs.  Treatment o Appropriate antibiotics o Surgical correction of obstruction or structural abnormality that might be causing urine retention o Urinary Tract Infection (cont’d)
  • 22. 429     Prevention: 1. Avoid products that may irritate the urethra (e.g., bubble bath, scented feminine products). 2. Cleanse the genital area before sexual intercourse. 3. Change soiled diapers in infants and toddlers promptly. 4. Drink plenty of water to remove bacteria from the urinary tract. 5. Do not routinely resist the urge to urinate 6. Take showers instead of baths. 7. Urinate after sexual intercourse. 8. Women and girls should wipe from front to back after voiding to prevent contaminating the urethra with bacteria from the anal area. Urolithiasis (Kidney Stones)  Urolithiasis: The process of forming stones in the kidney, bladder, and/or urethra (urinary tract).  Etiology: 1. Immobility. 2. Hypercalcemia. 3. UTIs. 4. Urine stasis. 5. Fractures.  Clinical Manifestations: 1. Renal colic. 2. Nausea and vomiting accompanying severe pain. 3. Fever and chills. 4. Hematuria. 5. Rarely, oliguria or anuria. 6. Bladder distension (urine retention)  Diagnostic tests: 1. KUB radiograph reveals visible calculi. 2. IVP (Intravenous Pyelogram) determines size and location of calculi. 3. Renal Ultrasonography reveals obstructive changes.
  • 23. 430     Treatment 1. Preventative measures include increased fluid intake, acidification of the urine and reduction of serum uric acid levels. 2. Surgical removal of stones. 3. Lithotripsy— Ultrasonic destruction of stones. Fragmented stones may then pass naturally with the urine. Renal tumors  Tumors of the kidney may be either :  rare benign Adenomas or, more commonly, malignant renal cell carcinomas  If benign adenomas arise, they tend to be small and usually not clinically significant.  The prognosis for renal cell carcinomas depends upon the morphology of the cells involved and the extent of spread outside the kidney.  Renal carcinomas may metastasize to the lymphatic system, liver, lungs and bone marrow.  Wilm’s tumor (nephroblastoma) o Rare malignant tumor that arises in infants and children. o The tumor presents with unique histology that may resemble embryonic kidney. o Tumor can metastasize rapidly.  Manifestations o Hematuria o Flank pain o Weight loss o Many renal tumors asymptomatic until the tumor is of advanced size and begins to disrupt renal structures o Metastatic tumors that can occur with advanced disease  Treatment o Chemotherapy, radiation therapy o Surgical removal of tumors Polycystic kidney disease  Hereditary disease characterized by cyst formation and massive kidney enlargement.  It can be Autosomal dominant (adult form) or autosomal recessive (childhood form)
  • 24. 431     Pathophysiology:  Renal cysts are fluid-filled sacs affecting nephrons; cysts fill, enlarge, multiply thus compressing and obstructing kidney tissue; renal parenchyma atrophies, becomes fibrotic and there is a progressive loss of renal function that may culminate in renal failure.  Cysts occur elsewhere in body including liver, spleen  Cysts develop in both kidneys and gradually increase in size. As normal kidney tissue is destroyed by the enlarging cysts The recessive form of the disease may cause renal failure in childhood while the dominant form progresses more slowly and generally does not lead to renal failure until patients enter their 60s or 70s.  Adult form accounts for 10% of persons in End Stage Renal Disease (ESRD)  Manifestations o Grossly enlarged kidneys o Hypertension from activation of the renin–angiotensin system o Renal insufficiency leading to renal failure o Pain in the flanks o Frequent infections  Treatment o Management of renal insufficiency and renal failure with dialysis o Management of hypertension; patients may be at particular risk for aneurysms and cerebral hemorrhage o Renal transplantation o Antibiotics for frequent infections
  • 25. 432    Renal failure  Renal failure refers to a significant loss of renal function in both kidneys to the point where less than 10 to 20% of normal GFR remains.  Renal failure may occur as an acute and rapidly progressing process or may present as a chronic form in which there is a progressive loss of renal function over a number of years. Acute renal failure  Abrupt decrease in renal function.  Regarding the causes of acute renal failure may be prerenal, intrarenal or postrenal in nature.  Acute renal failure is often reversible so long as permanent injury to the kidney has not occurred.  Causes of Acute Renal Failure Prerenal failure o Caused by impaired or reduced blood flow to the kidney Possible causes: shock, hypotension, anaphylaxis, sepsis Unless blood flow and oxygen delivery are restored permanent damage to the kidney will result Intrarenal failure o Results from acute damage to renal structures o Possible causes: acute glomerulonephritis, pyelonephritis, may also result from acute tubular necrosis (ATN), which is damage of kidney structure from exposure to toxins, solvents, drugs and heavy metals; ATN is the most common cause of acute renal failure, it accounts 50% of cases of acute renal failure o Antibiotics & NSAIDs. Postrenal failure o Results from conditions that block urine outflow Possible causes: obstruction of urine outflow by calculi, tumors, prostatic hypertrophy  Manifestations o Oliguria (reduced urine output) o Possible edema and fluid retention o Elevated blood urea nitrogen levels (BUN) and serum creatinine o Alterations in serum electrolytes
  • 26. 433     Treatment o Prevention of acute renal failure through support of blood pressure and blood volume o Correction of fluid and electrolyte imbalances o Dialysis, which may be employed while the kidneys are in the recovery phase o Low protein, high carbohydrate diet to minimize the formation of nitrogenous wastes Chronic renal failure  Chronic renal failure is the end result of progressive kidney damage and loss of function.  Some of the possible causes of chronic renal failure: o Chronic glomerulonephritis o Chronic infections o Renal obstruction o Exposure to toxic chemicals, toxins or drugs (aminoglycoside antibiotics) o Diabetes o Hypertension o Nephrosclerosis (atherosclerosis of the renal artery) o Aminoglycoside antibiotics and nephrotoxicity  The aminoglycoside antibiotics are a widely used group of drugs that include agents such as streptomycin, gentamicin and kanamycin.  The aminoglycosides can be nephrotoxic under certain conditions. Aminoglycoside toxicity is most likely to occur in elderly people, those with renal insufficiency or with chronic use.  Concurrent use of loop diuretics may also compound the adverse renal effects of the aminoglycosides.
  • 27. 434     Chronic renal failure is often classified into four progressive stages based on the loss of GFR 1) Diminished renal reserve — GFR decreased to 35 to 50% of normal 2) Renal insufficiency — GFR decreased to 20 to 35% of normal 3) Renal failure — GFR reduced to less than 20% of normal 4) End-Stage Renal Disease (ESRD) — GFR is less than 5% of normal  Because the kidneys play such an essential role in a number of physiologic processes, renal failure is a multisystem disease.  The kidneys have a tremendous reserve capacity for function and as a result overt symptoms generally do occur until renal insufficiency is present.  Vicious cycle of chronic renal failure There are several physiologic adaptations that occur in the kidneys in response to chronic renal failure: o Increased renal blood flow and GFR in functional nephrons o Hypertrophy of functional nephrons o In the short term these adaptations may be beneficial, but in the long term the increased pressure in the kidneys and increased oxygen demand can further damage the nephrons and worsen renal failure.  Clinical Manifestations: 1. Decreased appetite and energy level 2. Increased urinary output and fluid intake 3. Bone or joint pain 4. Delayed or absent sexual maturation 5. Growth retardation 6. Dryness and itching of skin 7. Anemia 8. Markedly elevated BUN and creatinine  Diagnostic Evaluation: o Determine extent of disease; monitor progression. 1. Serum studies a. Decreased hematocrit, hemoglobin, Na+, Ca++; increased K+, phosphorous b. As renal function declines, BUN, uric acid, and creatinine values continue to climb.
  • 28. 435    2. Urine studies: a. Specific gravity—increased or decreased b. 24-hour urine for creatinine clearance is decreased (increased creatinine in urine) reflecting decreased GFR. c. Changes in total output 3. Many other tests may be ordered to evaluate other systems and extent of disease (ie, chest x- ray, electrocardiogram)  Chronic renal failure Complications  Chronic Renal Failure Treatment 1. Correction of calcium phosphorous imbalance. Administer activated vitamin D to increase calcium absorption and calcium phosphate binders with meals to bind phosphate in the gastrointestinal tract. 2. Correction of acidosis with buffers such as Bicitra 3. Diets should meet caloric needs of the child containing adequate protein for development (1.0–1.5 g/kg per day). 4. Correction of anemia through the use of erythropoietin (Epogen) administered subcutaneously at home 5. Growth retardation should be evaluated for possible use of growth hormone. 6. Treatment options for end-stage renal disease (ESRD) are hemodialysis, peritoneal dialysis, or transplantation. 7. Institute dialysis therapy while transplant work-up is in progress.
  • 29. 436    Chronic Renal Failure Summary Hemodialysis  Hemodialysis is a procedure in which an “artificial kidney” machine takes the place of the patient’s own failing kidneys. Using an indwelling catheter, blood is withdrawn from the patient and passed through a chamber containing a dialysis membrane and clean dialysate solution.  Waste products that are in high concentration in the patient’s blood diffuse across the dialysate membrane and into the dialysate solution.  The cleaned blood is then returned to the patient via a second catheter.  Complications to hemodialysis can include risk of infection, hypotension and electrolyte imbalance.  Patients receiving hemodialysis must undergo the procedure several times per week for 3 to 6 hours per treatment.  Newer high flux dialysate membranes and improved dialysate solutions have reduced the time of each dialysis session by 1 to 2 hours.
  • 30. 437    Peritoneal dialysis  An alternative to classic hemodialysis is a technique called peritoneal dialysis. With this technique a “permanent” catheter is implanted into the peritoneal cavity.  A clean dialysate solution is introduced through this catheter into the peritoneal cavity and the patient’s own peritoneum (the membrane lining the abdominal cavity) is used as the dialyzing membrane.  After a fixed period of time, usually 8 to 48 hours depending on the system and the frequency of dialysis, the used fluid is withdrawn.  Complications of this technique may include infections from the catheter, hypotension, edema and metabolic abnormalities.  Peritoneal dialysis does, however, offer the advantage that it may be performed in a patient’s own home and overnight when the patient sleeps.
  • 31. 438    Kidney Transplantation  The transplant surgery is performed under general anesthesia.  The operation usually takes 2-4 hours.  This type of operation is a heterotopic transplant meaning the kidney is placed in a different location than the existing kidneys.  (Liver and heart transplants are orthotopic transplants, in which the diseased organ is removed and the transplanted organ is placed in the same location.)  The kidney transplant is placed in the front (anterior) part of the lower abdomen, in the pelvis.  The original kidneys are not usually removed unless they are causing severe problems such as uncontrollable high blood pressure, frequent kidney infections, or are greatly enlarged.  The artery that carries blood to the kidney and the vein that carries blood away is surgically connected to the artery and vein already existing in the pelvis of the recipient. The ureter is connected to the bladder.  Recovery in the hospital is usually 3-7 days.  Complications can occur with any surgery.  The following complications do not occur often but can include: o Bleeding, infection, or wound healing problems. o Difficulty with blood circulation to the kidney or problem with flow of urine from the kidney.  These complications may require another operation to correct them.  Rejection is an expected side effect of transplantation and up to 30% of people who receive a kidney transplant will experience some degree of rejection.  Most rejections occur within six months after transplantation, but can occur at any time, even years later. Prompt treatment can reverse the rejection in most cases.  Anti-Rejection Medications: o Anti-rejection medications, also known as immunosuppressive agents, help to prevent and treat rejection. o They are necessary for the "lifetime" of the transplant. If these medications are stopped, rejection may occur and the kidney transplant will fail.
  • 33. 440    Disorders of the bladder and urethra Urine reflux  Urine reflux is the backward flow of urine from the bladder into the ureters and kidneys (vesicoureteral reflux) or from the urethra into the bladder (urethrovesical reflux)  Generally results from congenital abnormalities in the structure or location of the ureters or urethra.  Patients often present with urine retention and recurrent urinary tract infections.  Treatment may include antibiotic therapy and possible surgical correction of the structural abnormality. Neurogenic bladder  Bladder paralysis that occurs from interruption of nervous input to the muscles of the bladder wall.  Patients are unable to voluntarily or involuntarily empty their bladder.  Causes may include spinal cord trauma, polio, multiple sclerosis and tumors affecting spinal nerves.  Manifestations include marked urine retention, frequent urinary tract infections and possible deterioration of renal function (postrenal failure). _____________________